Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort Study-Reference-Cited by-同舟云学术

Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort Study

Published:2023-05 Issue: Volume: Page:
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Wiesel Vered^ORCID,Aviram Micha^ORCID,Mei-Zahav Meir^ORCID,Dotan Miri^ORCID,Prais Dario,Cohen-Cymberknoh Malena,Gur Michal,Bar-Yoseph Ronen^ORCID,Livnat Galit^ORCID,Goldbart Aviv,Hazan Guy,Hazan Itai^ORCID,Golan-Tripto Inbal^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference43 articles.

1. Increasing nontuberculous mycobacteria infection in cystic fibrosis;Bar-On;J Cyst Fibros,2015

2. Risk factors for nontuberculous mycobacterial isolation in patients with cystic fibrosis: A meta-analysis;Reynaud;Pediatr Pulmonol,2020

3. 2020 Patient Registry Annual Data Report 2020:100.

4. ECFS Patient Registry n.d.

5. Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis;Qvist;J Cyst Fibros,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division;International Journal of Antimicrobial Agents;2024-10

2. Cystic fibrosis;Nature Reviews Disease Primers;2024-08-08

3. Nontuberculous Mycobacteria Pulmonary Infection in Children with Cystic Fibrosis;Current Infectious Disease Reports;2024-08-02

4. Cystic fibrosis year in review 2023;Pediatric Pulmonology;2024-07-26

5. Growing from common ground: nontuberculous mycobacteria and bronchiectasis;European Respiratory Review;2024-07